Position in JNJ
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$12,975,073
+$625,965 QoQ
Shares Held
51,089
+1.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.49%
of 13F equity value
Holder Rank
#957
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SUMMITRY LLC holds $46,849,010 across 11 Drug Manufacturers - General names. JNJ ranks #2 (27.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
75,057 | $27,179,640 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
51,089 | $12,975,073 | |
| 3 | LLY |
ELI LILLY & Co
|
1,711 | $2,052,224 | |
| 4 | ABBV |
AbbVie Inc.
|
4,563 | $1,148,233 | |
| 5 | BIIB |
Biogen Inc.
|
4,137 | $893,840 | |
| 6 | MRK |
Merck & Co., Inc.
|
6,279 | $806,851 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
8,531 | $491,556 | |
| 8 | NVS |
Novartis AG
|
2,464 | $386,158 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,975,073 | 51,089 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $12,349,108 | 50,520 | Shares | Sole | 2026-05-22 | |
| 2025-12-31 | $10,959,451 | 52,957 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $9,456,976 | 51,003 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $7,202,162 | 47,150 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $6,996,789 | 42,190 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $5,276,605 | 36,486 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $5,174,413 | 31,929 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $4,568,523 | 31,257 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $4,676,254 | 29,561 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $4,634,958 | 29,571 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $4,386,075 | 28,161 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $4,490,557 | 27,130 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $4,073,245 | 26,279 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $4,391,872 | 24,862 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $3,883,393 | 23,772 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $3,868,830 | 21,795 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $4,176,956 | 23,568 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $4,297,962 | 25,124 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $3,999,547 | 24,765 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $4,617,332 | 28,028 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $4,408,195 | 26,822 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $4,104,470 | 26,080 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $3,516,992 | 23,623 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $3,329,696 | 23,677 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $2,746,255 | 20,943 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||